Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Regulatory explorer
Regulatory document

FDA notice: comment request on animal food additive information collections

A December 2024 FDA notice invites 60 days of public comment on proposed information collections about animal food additives, petitions, investigational file exemptions and label declarations. [1]

Automatic summary · not editorially reviewed

The key findings

  1. The FDA notice was published on 19 December 2024 and concerns proposed information collections. [1]

  2. The Paperwork Reduction Act requires a 60-day public comment period for such notices. [1]

  3. The web rendition is informational, not the official legal edition, and a notice is not a final rule. [1]

The source at a glance

Jurisdiction
US
Authority
Health and Human Services Department; Food and Drug Administration
Document type
Notice
Record type / format
Notice
Scope / context
Proposed FDA information collections on food additives for animal food, food additive petitions, investigational file exemptions and color additive declarations on animal food labels.
Summary based on
Official regulatory document
Original publication
December 19, 2024

FDA notice on animal food additive collections

This is a United States notice from the Health and Human Services Department and the Food and Drug Administration, published on 19 December 2024. Under the Paperwork Reduction Act of 1995, federal agencies must publish a Federal Register notice for each proposed information collection, including extensions, and allow 60 days for public comment. This notice solicits comments on the information collection provisions tied to food additives intended for use in animal food, food additive petitions, investigational food additive file exemptions and declaration of color additives on animal food labels.

Supporting source [1]

Comment window and informational web rendition

The notice opens a 60-day comment period on the proposed collection. The supplied web/API rendition is described as an informational resource, not the official legal edition. Readers are directed to verify the linked official PDF on GovInfo and any later amendments before relying on legal requirements. The source states that a proposed rule or notice is not a final rule, and that a publication date is not necessarily an effective date.

Supporting source [1]

Scope of this notice record

The supplied material is the agency abstract and metadata, not the full document. It does not determine a product's compliance or current legal status, and it is not a determination of current law. The documented subject is the proposed information collection itself, not patients or a clinical population. No biological aging topic is covered by this regulatory record.

Supporting source [1]

How to interpret this

Document summary; not a determination of current law. Based only on the agency abstract and metadata; the full document was not reviewed. The web/API rendition is informational, not the official legal edition; verify the linked official PDF on GovInfo and later amendments. A notice is not a final rule, and a publication date is not necessarily an effective date.

Based on the cited official document. Its jurisdiction, document type and effective date matter; a proposal or notice is not a rule already in force.

Source & supporting passages

Read the quoted passagesIn the language of the original source
  1. Finding 1 ↑

    is announcing an opportunity for public comment
  2. Finding 2 ↑

    to allow 60 days for public comment
  3. Finding 3 ↑

    A proposed rule or notice is not

AI-assisted summary with linked source passages. No independent editorial or clinical review.

Our editorial method

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…